PharmaCielo (TSE:PCLO) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PharmaCielo, a leading cultivator and producer of cannabis extracts, has announced an anticipated reinstatement for trading on the TSX Venture Exchange following a successful resolution of previous regulatory issues. The company has also been progressing with its efficiency program, reducing its monthly cash burn rate, and is finalizing a private placement to boost its finances. Additionally, PharmaCielo is extending its international footprint with an impending acquisition of Siam Ventures Corporation in Thailand.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.